Previous Close | 226.76 |
Open | 228.00 |
Bid | 227.01 x 800 |
Ask | 231.50 x 1200 |
Day's Range | 226.14 - 228.56 |
52 Week Range | 156.72 - 231.86 |
Volume | |
Avg. Volume | 1,275,027 |
Market Cap | 65.045B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | 42.21 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.28 (1.00%) |
Ex-Dividend Date | Jun 18, 2024 |
1y Target Est | N/A |
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.